News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affymetrix (Santa Clara, California) (AFFX) And Genisphere Launch Best-in-Class Solution for microRNA Expression Research


3/16/2009 9:01:42 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (Nasdaq:AFFX) and Genisphere Inc. today announced the launch of a new, best-in-class solution for microRNA (miRNA) research studies. Encompassing assay, array, and software, the solution offers comprehensive miRNA coverage for 71 organisms on a single array. Covered species include human, mouse, rat, canine, and monkey — all of which are critical models for pharmaceutical and academic scientists working in oncology, stem cell research, toxicology, neuroscience, infectious disease, and many other areas.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES